Jade Biosciences, Inc. (JBIO) Operating cash flow 2020–2025
Jade Biosciences, Inc. (JBIO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$94.7MFY2025 · since FY2020: -$7.9M → -$94.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$94.7M | -33.0% |
| FY2024 | -$71.2M | -25.4% |
| FY2023 | -$56.8M | -45.1% |
| FY2022 | -$39.1M | -42.8% |
| FY2021 | -$27.4M | -248.6% |
| FY2020 | -$7.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More JBIO financial trends
JBIO RevenueJBIO Net incomeJBIO Net marginJBIO Gross profitJBIO Gross marginJBIO Operating incomeJBIO Operating marginJBIO Free cash flowJBIO Capital expendituresJBIO Return on equityJBIO Stock buybacksJBIO Dividends paidJBIO Total assetsJBIO Total liabilitiesJBIO Shareholders’ equityJBIO overview →